Risk of Development of Resistance in Patients with Non-Cystic Fibrosis Bronchiectasis Treated with Inhaled Antibiotics.

Kate H ReganAdam T Hill

Published in: Current pulmonology reports (2018)

There is no convincing evidence of treatment-emergent pathogens or pathogens developing resistance to the inhaled antibiotic therapy.

Keyphrases